• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD8 T细胞在结直肠癌免疫治疗中的作用。

The role of CD8 T-cells in colorectal cancer immunotherapy.

作者信息

He Tao, Hu Chencheng, Li Shichao, Fan Yao, Xie Fei, Sun Xin, Jiang Qingfeng, Chen Weidong, Jia Yingtian, Li Wusheng

机构信息

The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou City, Sichuan Province, China.

出版信息

Heliyon. 2024 Jun 15;10(12):e33144. doi: 10.1016/j.heliyon.2024.e33144. eCollection 2024 Jun 30.

DOI:10.1016/j.heliyon.2024.e33144
PMID:39005910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11239598/
Abstract

Immunotherapy has been an advanced and effective approach to treating various types of solid tumors in recent years, and the most successful strategy is immune checkpoint inhibitors (ICIs), which have shown beneficial effects in patients with colorectal cancer (CRC). Drug resistance to ICIs is usually associated with CD8 T-cells targeting tumor antigens; thus, CD8 T-cells play an important role in immunotherapy. Unfortunately, Under continuous antigen stimulation, tumor microenvironment(TME), hypoxia and other problems it leads to insufficient infiltration of CD8 T-cells, low efficacy and mechanism exhaustion, which have become obstacles to immunotherapy. Thus, this article describes the relationship between CRC and the immune system, focuses on the process of CD8 T-cells production, activation, transport, killing, and exhaustion, and expounds on related mechanisms leading to CD8 T-cells exhaustion. Finally, this article summarizes the latest strategies and methods in recent years, focusing on improving the infiltration, efficacy, and exhaustion of CD8 T-cells, which may help to overcome the barriers to immunotherapy.

摘要

近年来,免疫疗法已成为治疗各类实体瘤的一种先进且有效的方法,最成功的策略是免疫检查点抑制剂(ICIs),其已在结直肠癌(CRC)患者中显示出有益效果。对ICIs的耐药性通常与靶向肿瘤抗原的CD8 T细胞相关;因此,CD8 T细胞在免疫疗法中发挥着重要作用。不幸的是,在持续的抗原刺激下,肿瘤微环境(TME)、缺氧以及其导致的CD8 T细胞浸润不足、疗效低下和机制耗竭等问题,已成为免疫疗法的障碍。因此,本文描述了结直肠癌与免疫系统之间的关系,重点关注CD8 T细胞的产生、激活、运输、杀伤和耗竭过程,并阐述导致CD8 T细胞耗竭的相关机制。最后,本文总结了近年来的最新策略和方法,重点在于改善CD8 T细胞的浸润、疗效和耗竭情况,这可能有助于克服免疫疗法的障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a59/11239598/d4dfd1586f38/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a59/11239598/aae11a0c389f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a59/11239598/d4dfd1586f38/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a59/11239598/aae11a0c389f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a59/11239598/d4dfd1586f38/gr2.jpg

相似文献

1
The role of CD8 T-cells in colorectal cancer immunotherapy.CD8 T细胞在结直肠癌免疫治疗中的作用。
Heliyon. 2024 Jun 15;10(12):e33144. doi: 10.1016/j.heliyon.2024.e33144. eCollection 2024 Jun 30.
2
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.肿瘤免疫微环境中耗竭的CD8 + T细胞:新的治疗途径
Front Immunol. 2021 Feb 2;11:622509. doi: 10.3389/fimmu.2020.622509. eCollection 2020.
3
Unveiling YWHAH: A potential therapeutic target for overcoming CD8 T cell exhaustion in colorectal cancer.揭示 YWHAH:克服结直肠癌中 CD8 T 细胞耗竭的潜在治疗靶点。
Int Immunopharmacol. 2024 Jun 30;135:112317. doi: 10.1016/j.intimp.2024.112317. Epub 2024 May 25.
4
High HPK1PD-1TIM-3CD8 T cells infiltration predicts poor prognosis to immunotherapy in NSCLC patients.高 HPK1PD-1TIM-3CD8+T 细胞浸润预示非小细胞肺癌患者免疫治疗预后不良。
Int Immunopharmacol. 2024 Jan 25;127:111363. doi: 10.1016/j.intimp.2023.111363. Epub 2023 Dec 15.
5
Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy.肿瘤内 Treg 细胞的空间和功能靶向逆转 CD8+ T 细胞耗竭并促进癌症免疫治疗。
J Clin Invest. 2024 May 23;134(14):e180080. doi: 10.1172/JCI180080.
6
Global Pattern of CD8 T-Cell Infiltration and Exhaustion in Colorectal Cancer Predicts Cancer Immunotherapy Response.结直肠癌中CD8 T细胞浸润和耗竭的全球模式可预测癌症免疫治疗反应。
Front Pharmacol. 2021 Sep 10;12:715721. doi: 10.3389/fphar.2021.715721. eCollection 2021.
7
Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer.肿瘤内注射干扰素 γ 可增强抗 PD-1 治疗结直肠癌的疗效。
Cancer Lett. 2024 Apr 28;588:216798. doi: 10.1016/j.canlet.2024.216798. Epub 2024 Mar 11.
8
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞:综述。
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.
9
Improving the efficacy of immunotherapy for colorectal cancer: Targeting tumor microenvironment-associated immunosuppressive cells.提高结直肠癌免疫治疗疗效:靶向肿瘤微环境相关免疫抑制细胞
Heliyon. 2024 Aug 16;10(16):e36446. doi: 10.1016/j.heliyon.2024.e36446. eCollection 2024 Aug 30.
10
Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment.溶瘤病毒通过重编程实体瘤微环境来改善癌症免疫治疗。
Med Oncol. 2023 Dec 8;41(1):8. doi: 10.1007/s12032-023-02233-0.

引用本文的文献

1
Spatial transcriptomics and scRNA-seq: decoding tumor complexity and constructing prognostic models in colorectal cancer.空间转录组学与单细胞RNA测序:解析结直肠癌的肿瘤复杂性并构建预后模型
Hum Genomics. 2025 Aug 13;19(1):92. doi: 10.1186/s40246-025-00805-x.
2
Gut Microbiota Reshapes the Tumor Microenvironment and Affects the Efficacy of Colorectal Cancer Immunotherapy.肠道微生物群重塑肿瘤微环境并影响结直肠癌免疫治疗的疗效。
Cancer Med. 2025 Jun;14(12):e70994. doi: 10.1002/cam4.70994.

本文引用的文献

1
Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond.靶向肿瘤免疫治疗中的髓源抑制细胞:当前、未来及以后。
Front Immunol. 2023 Mar 17;14:1157537. doi: 10.3389/fimmu.2023.1157537. eCollection 2023.
2
A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer.一种新型纤维调节素拮抗剂肽RP4对结直肠癌具有抗肿瘤作用。
Pharmaceutics. 2023 Mar 14;15(3):944. doi: 10.3390/pharmaceutics15030944.
3
Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis.
载脂蛋白 L3 通过促进 LDHA 介导的铁死亡增强结直肠癌 CD8+T 细胞抗肿瘤免疫。
Int J Biol Sci. 2023 Feb 13;19(4):1284-1298. doi: 10.7150/ijbs.74985. eCollection 2023.
4
Probiotic powder ameliorates colorectal cancer by regulating Bifidobacterium animalis, Clostridium cocleatum, and immune cell composition.益生菌粉通过调节动物双歧杆菌、柯林斯氏菌和免疫细胞组成来改善结直肠癌。
PLoS One. 2023 Mar 13;18(3):e0277155. doi: 10.1371/journal.pone.0277155. eCollection 2023.
5
Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance.组织驻留的lachnospiraceae 家族细菌通过促进肿瘤免疫监测来预防结直肠癌发生。
Cell Host Microbe. 2023 Mar 8;31(3):418-432.e8. doi: 10.1016/j.chom.2023.01.013.
6
Colorectal cancer statistics, 2023.2023 年结直肠癌统计数据。
CA Cancer J Clin. 2023 May-Jun;73(3):233-254. doi: 10.3322/caac.21772. Epub 2023 Mar 1.
7
Mesenchymal stem cells elicits Anti-PD1 immunotherapy by targeted delivery of CX3CL1.间充质干细胞通过CX3CL1的靶向递送引发抗PD1免疫疗法。
Front Pharmacol. 2023 Feb 8;14:1136614. doi: 10.3389/fphar.2023.1136614. eCollection 2023.
8
Checkpoint TIPE2 Limits the Helper Functions of NK Cells in Supporting Antitumor CD8 T Cells.检查点 TIPE2 限制 NK 细胞在支持抗肿瘤 CD8 T 细胞中的辅助功能。
Adv Sci (Weinh). 2023 Apr;10(12):e2207499. doi: 10.1002/advs.202207499. Epub 2023 Feb 19.
9
Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.肿瘤相关巨噬细胞在结直肠肿瘤进展中运用免疫编辑机制:巨噬细胞重极化免疫治疗的当前研究。
Int Immunopharmacol. 2023 Mar;116:109569. doi: 10.1016/j.intimp.2022.109569. Epub 2023 Feb 9.
10
Targeting mA reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer.靶向 mA 读者 YTHDF1 增强抗肿瘤免疫并提高结直肠癌的抗 PD-1 疗效。
Gut. 2023 Aug;72(8):1497-1509. doi: 10.1136/gutjnl-2022-328845. Epub 2023 Jan 30.